MF
IRMD icon

Magnetar Financial’s iRadimed IRMD Stock Holding History

Magnetar Financial’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,330
Closed -$618K – 1029
2025
Q2 		$618K Sell
10,330
-1,517
-13% -$83.1K ﹤0.01% 519
2025
Q1 		$622K Buy
11,847
+645
+6% +$36.2K 0.01% 418
2024
Q4 		$616K Buy
11,202
+6,312
+129% +$332K 0.01% 341
2024
Q3 		$246K Sell
4,890
-1,576
-24% -$72.7K 0.01% 435
2024
Q2 		$284K Buy
+6,466
New +$275K 0.01% 393

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Magnetar Financial's IRMD Position: Q3 2025 in Review

Magnetar Financial sold out of iRadimed (IRMD) in Q3 2025, closing a stake of 10,330 shares — an estimated $618K sold.

Magnetar Financial first reported a position in IRMD in Q2 2024 and held it in 5 quarters. The position peaked at $622K in Q1 2025. 185 funds tracked by Wall St. Rank hold IRMD as of Q3 2025.

  • Magnetar Financial reported no remaining iRadimed position as of Q3 2025 after selling out during the quarter.
  • Magnetar Financial sold 10,330 iRadimed shares in Q3 2025, an estimated $618K.
  • Magnetar Financial first reported a position in iRadimed in Q2 2024 and held it in 5 quarters.
  • Magnetar Financial's iRadimed position peaked at $622K in Q1 2025.
  • 185 funds tracked by Wall St. Rank held iRadimed as of Q3 2025.

Based on Magnetar Financial's 13F filing for Q3 2025, filed 13 Nov 2025.